跳至主要内容
临床试验/NCT03219307
NCT03219307进行中(未招募)3 期

Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture

Aesculap Biologics, LLC10 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2018年11月30日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
30
试验地点
10
主要终点
KOOS pain subdomain score

研究概览

简要总结

This study is prospective single arm extension study of protocol AAG-G-H-1220. It is open only to participants of AAG-G-H-1220 randomized to the Microfracture treatment group.

详细描述

This study is an extension of protocol AAG-G-H-1220 wherein patients were randomized to either NOVOCART 3D or Microfracture treatment groups. This prospective single arm extension study is only open to participants of AAG-G-H-1220 who were randomized to Microfracture treatment and who failed Microfracture treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • participated in study AAG-G-H-1220
  • identified as a microfracture failure patient
  • voluntary consent to participate in the study

排除标准

  • other cartilage repair procedures performed on target knee
  • other conditions that would interfere with healing or evaluating outcomes
  • lesions requiring implants larger than 9cm2
  • non-compliance with requirements in study AAG-G-H-1220

结局指标

主要结局

KOOS pain subdomain score

时间窗: 24 months

Comparison of pain scores from the KOOS questionnaire from baseline

次要结局

  • IKDC subjective scores(24 months)
  • KOOS function subdomain score(24 months)
  • VAS pain scale(24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验